Oncocyte’s Strategic Collaboration and Financial Discipline Highlight First Quarter Achievements
Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, reported key financial results and strategic developments for Q1 2024. The company announced a significant $15.8 million equity private placement and a global commercialization partnership with Bio-Rad Laboratories, Inc.
CEO Josh Riggs emphasized the importance of these milestones in advancing Oncocyte’s innovative blood-based diagnostic tests. The partnership with Bio-Rad is pivotal for the launch of Oncocyte’s GraftAssure™ RUO transplant rejection diagnostic test kit, expected to ship to initial customers in Asia, the U.S., and the EU in Q2 2024. Additionally, VitaGraft™ Kidney IVD kits for FDA submission are under development.
The strategic alliance with Bio-Rad, which now holds 8.99% of Oncocyte, validates the market potential of Oncocyte’s proprietary assays and facilitates the company’s entry into the growing transplant monitoring market. Oncocyte aims to meet critical commercial and regulatory milestones throughout 2024 and 2025.
Financially, Oncocyte reduced its cash burn to $3.9 million, demonstrating a capital-efficient business model. Despite a 41% drop in net revenue to $176,000, attributed to decreased Pharma Services business revenue, the company maintained focused R&D investments, particularly for developing kitted versions of its assays. Sales and marketing expenses rose by 22% to $846,000, supporting the GraftAssure commercial launch.
General and administrative expenses fell by 22% to $2.7 million, reflecting decreased stock-based compensation and other costs. However, Oncocyte reported a loss from operations of $9.3 million, largely due to a noncash change in fair value of contingent consideration.
Oncocyte remains committed to its goal of maintaining a low average quarterly burn rate below $5 million, positioning the company for sustained progress in diagnostics and commercialization efforts.
Clickhereto read the original press release.
You might like this article:Uber Unveils Innovative Features at Go-Get Showcase to Enhance User Experience
